High potency stable formulations of vaginal lactobacillus
AssigneeOsel, Inc.
InventorsThomas P. Parks, Angela Marcobal
Life of this patent
Estimating the term…
Abstract
This invention provides for a dry preserved formulation of Lactobacillus suitable for administration to people as a pro-biotic or live biotherapeutic treatment where the formulation is stable, has high potency, and contains no animal-derived excipients.
Claims20
An aqueous bacterial suspension of vaginal Lactobacillus species, having no animal-derived excipients, where the suspension results from a combination of a cell pellet of vaginal Lactobacillus species with an aqueous preservation medium consisting essentially of:
- (i) trehalose at between 5-20%, w/v;
- (ii) xylitol at between 2-9%, w/v;
- (iii) sodium ascorbate 0.5-1.5%, w/v;
- and
- (iv) sodium phosphate at between 10-50 mM.
A method of preserving Lactobacillus spp. under dry conditions without animal-derived excipients, the method comprising:
- (i) obtaining an aqueous suspension of vaginal Lactobacillus species having a cell concentration between 108 to 1013 per ml;
- (ii) centrifuging the solution to form a bacterial cell pellet;
- and
- (iii) resuspending the bacterial cell pellet in an aqueous preservation medium consisting essentially of:
- (a) trehalose at between 5-20%, w/v;
- (b) xylitol at between 2-9%, w/v;
- (c) sodium ascorbate 0.5-1.5%, w/v;
- and
- (d) sodium phosphate at between 10-50 mM;
- where the weight ratio of cell pellet wet weight (grams) to preservation media (mL) is between 1:1 and 1:5 grams of cell pellet to milliliter of preservation media to yield a bacterial suspension.
Dependencies are inferred from the claim text.